17
Participants
Start Date
November 15, 2022
Primary Completion Date
July 15, 2024
Study Completion Date
July 15, 2024
Etavopivat
400 mg once daily
NYU Langone Health, New York
Columbia University Irving Medical Center, New York
University of Miami Hospital and Clinics, Miami
Centre Hospitalier Universitaire de Bordeaux-Hopital Haut Leveque-1, Pessac
Ocala Oncology, Ocala
Charite Universitätsmedizin Berlin, Mainz
Universitätsklinikum Leipzig, Klinik und Poliklinik, Mainz
Master centre for France, Paris La Défense
Cedars-Sinai Medical Center, Plainsboro
Northwell Health, Plainsboro
Northwestern Memorial Hospital, Plainsboro
The Ohio State University Medical Center, Plainsboro
University of British Columbia - St. Paul's Hospital, Vancouver
Nice University Hospital - Hôpital de l'Archet, Route de Saint-Antoine
Hopital Saint Louis, Paris
Universitoetsklinikum Heidelberg, Heidelberg
Universitaetsklinikum Muenster, Münster
Universitoetsklinikum Halle (Saale), Münster
Lead Sponsor
Forma Therapeutics, Inc.
INDUSTRY